Biosimilars: A revolution for biologics in the pharmaceutical industry
This project report is submitted in partial fulfilment of the requirements for the degree of Bachelor of Pharmacy, 2017.
Главный автор: | Moreino, Shannon Sherwin |
---|---|
Другие авторы: | Kabir, Eva Rahman |
Формат: | Project report |
Язык: | English |
Опубликовано: |
BRAC University
2018
|
Предметы: | |
Online-ссылка: | http://hdl.handle.net/10361/9331 |
Схожие документы
-
Biologics and Biosimilars as Treatment Options for Psoriasis
по: Moya, Amena Khatun
Опубликовано: (2023) -
Biosimilar in lymphoma treatment
по: Tanisha, Mehrin Haque
Опубликовано: (2021) -
Biosimilar insulins: a potential option in the treatment of Diabetes
по: Tabassum, Turana
Опубликовано: (2022) -
Concepts and challenges of biosimilars to mitigate the oncology drug expenses
по: Tania, Umme
Опубликовано: (2021) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
по: Tania, Umme
Опубликовано: (2023)